Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
To learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G12C mutations.
Sponsor: M.D. Anderson Cancer Center
Check if you qualify for this colorectal cancer clinical trial in Boston, MA
If you're searching for colorectal cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.